LED Treatment to Improve Cognition and Promote Recovery in TBI
| Status: | Recruiting |
|---|---|
| Conditions: | Neurology, Psychiatric, Psychiatric |
| Therapuetic Areas: | Neurology, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 21 - 55 |
| Updated: | 3/30/2019 |
| Start Date: | May 1, 2015 |
| End Date: | October 30, 2020 |
| Contact: | Yelena Bogdanova, PhD PhD |
| Email: | Yelena.Bogdanova@va.gov |
| Phone: | (857) 364-2249 |
Noninvasive LED Treatment to Improve Cognition and Promote Recovery in Blast TBI
This study investigates the efficacy of a novel neuromodulation treatment, light emitting
diodes (LED), on cognition, neuropsychiatric status and quality of life in individuals with
traumatic brain injury (TBI).
diodes (LED), on cognition, neuropsychiatric status and quality of life in individuals with
traumatic brain injury (TBI).
The most common traumatic brain injury (TBI)-associated problems are cognitive deficits and
neuropsychiatric problems, such as sleep disturbance and PTSD. This study evaluates a novel
neuromodulation intervention, light emitting diodes (LED), for treatment of patients with
TBI. LED is a noninvasive, non-thermal, painless treatment, which does not involve any
needles or any form of surgery. LED treatment improves cellular activity of the brain tissue
that has been damaged by TBI. Half of the study participants will receive active LED
treatment, and a control group will receive sham LED. This study takes place in Boston,
Massachusetts: at the VA Boston Healthcare System.
neuropsychiatric problems, such as sleep disturbance and PTSD. This study evaluates a novel
neuromodulation intervention, light emitting diodes (LED), for treatment of patients with
TBI. LED is a noninvasive, non-thermal, painless treatment, which does not involve any
needles or any form of surgery. LED treatment improves cellular activity of the brain tissue
that has been damaged by TBI. Half of the study participants will receive active LED
treatment, and a control group will receive sham LED. This study takes place in Boston,
Massachusetts: at the VA Boston Healthcare System.
Inclusion Criteria:
Inclusion Criteria:
- OEF/OIF active-duty personnel or Veterans with history of TBI or blast-exposure
- Meets criteria for mild TBI
- LOC of 30 min or less
- Age: 21-55
- Primary language is English
Exclusion Criteria:
- Evidence of penetrating head injury
- History of previous neurological diagnosis
- History of previous psychotic disorder prior to TBI
- Hearing or vision impairment
We found this trial at
1
site
Boston, Massachusetts 02130
Principal Investigator: Yelena Bogdanova, PhD PhD
Phone: 857-364-2249
Click here to add this to my saved trials
